| abstract |
The invention relates to the use of the compounds of the general structure (I), or the pharmaceutically acceptable salts thereof, wherein X represents CR<4> or N, Y represents CR<5> or N, and X and Y are not simultaneously N, and W represents N or NR<8>. The novel compounds are used for producing a medicament for inhibiting NO synthase, for treating migraine and for treating septicemic shock, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's chorea, inflammations, inflammatory pains, cerebral ischemia, diabetes, meningitis, arteriosclerosis and/or for wound healing. |